Marketed in Spain the first medication derived from cannabis to treat refractory epilepsy
From September 2021, Cannabidiol (CBD) will be marketed in Spain as the first medication used to treat refractory epilepsy, which does not respond we1
From September 2021, Cannabidiol (CBD) will be marketed in Spain as the first medication used to treat refractory epilepsy, which does not respond we1
Interview with Dr. Lluïsa Garcia Esteve, psychiatrist and president of the Commission on Domestic and Gender-Based Violence
A study by CIBERSAM with the participation of Hospital Clínic-IDIBAPS found that treatment-resistant depression has a mean incidence in Spain of 0.931
An interview with Dr Albert Lladó, neurologist at the Alzheimer's and other Cognitive Disorders Unit. Dr Lladó treats dementias, including Alzheimer'1
Dr. Zoe Mariño was awarded a grant in the III Gilead Grant Applications devoted to projects focusing on Micro-elimination in Hepatitis C
Interview with Dr. Eduard Vieta, Head of the Psychiatry and Psychology Service
Patients with bipolar disorder are at greater risk of developing cancer at some point in their lifetime. A study carried out by the Hospital Clínic’s1
This Wednesday, the Hospital Clínic de Barcelona celebrated World Maternal Mental Health Day within the context of a day commemorated virtually and e1
A healthy diet and maintaining healthy habits will contribute to caring for your mental health. To highlight the importance of diet in mental health,1
Many families avoid talking to their children about death to protect them from possible pain or suffering. For this reason, they end up giving incorr1